Aprogen Medicines Inc. (KRX:007460)

Market Cap	196.72B
Revenue (ttm)	138.76B
Net Income (ttm)	-43.10B
Shares Out	298.51M
EPS (ttm)	-167.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,549,425
Average Volume	3,386,019
Open	687.00
Previous Close	688.00
Day's Range	677.00 - 732.00
52-Week Range	600.00 - 1,794.00
Beta	0.45
RSI	51.00
Earnings Date	Aug 12, 2025

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam...

• Industry: Conglomerates
• Sector: Industrials
• Founded: 1971
• Employees: 252
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 007460

Financial Performance

In 2024, Aprogen Medicines's revenue was 150.11 billion, a decrease of -0.31% compared to the previous year's 150.58 billion. Losses were -58.08 billion, 4.42% more than in 2023.